Top Headlines: Relief for pharma cos, ban to hit Chinese firms, and more

After representations from industry bodies, the government on Tuesday cleared imports of active pharma ingredients (APIs) from China. The Kishore Biyani-led Future group has zeroed in on SBI General to sell its majority stake in the general insurance joint venture, and on Premji Invest for its life insurance venture stake. Here are the top headlines on Wednesday morning.

Relief for pharma firms

Easing restrictions on imports from China, the Customs department has decided to clear pharma raw material shipments from that country. Consignments of 11 top importers, including LG, Samsung, Toyota, Honda, and Siemens, will also be allowed entry,